All Pharma News
Oncoinvent Announces Changes to its BODs and Clinical Advisory Board

Oncoinvent Announces Changes to its BODs and Clinical Advisory Board
BUSINESSWIRE
02 Apr 2024
Share Share
Oncoinvent to Present at Evercore ISI 2024 Emerging Biotech Conference

Oncoinvent to Present at Evercore ISI 2024 Emerging Biotech Conference
BUSINESSWIRE
21 Feb 2024
Share Share
Oncoinvent Announces U.S. FDA Clearance of IND Application for Radspherin

Oncoinvent Announces U.S. FDA Clearance of IND Application for Radspherin
BUSINESSWIRE
31 Oct 2023
Share Share
Oncoinvent Announces U.S. FDA Clearance of IND Application for Radspherin

Oncoinvent Announces U.S. FDA Clearance of IND Application for Radspherin
BUSINESSWIRE
27 Oct 2023
Share Share
Oncoinvent Presents 18-Month Safety and Efficacy Data from Ongoing RAD-18-002

Oncoinvent Presents 18-Month Safety and Efficacy Data from Ongoing RAD-18-002
BUSINESSWIRE
04 Oct 2023
Share Share
Oncoinvent To Present Initial Safety Data from the Phase 1 Trial of Radspherin

Oncoinvent To Present Initial Safety Data from the Phase 1 Trial of Radspherin
BUSINESSWIRE
28 Sep 2023
Share Share
Oncoinvent appoints Anders Månsson as CEO

Oncoinvent appoints Anders Månsson as CEO
BUSINESSWIRE
05 Jul 2023
Share Share
Oncoinvent to Present at TD Cowen Radiopharmaceutical Innovation Summit

Oncoinvent to Present at TD Cowen Radiopharmaceutical Innovation Summit
BUSINESSWIRE
16 Jun 2023
Share Share
Oncoinvent Presents Safety Data from RAD-18-002 Phase 1/2A Trial of Radspherin

Oncoinvent Presents Safety Data from RAD-18-002 Phase 1/2A Trial of Radspherin
BUSINESSWIRE
05 Jun 2023
Share Share
Oncoinvent Announces Two Publications in Special Edition of Frontiers Medicine

Oncoinvent Announces Two Publications in Special Edition of Frontiers Medicine
BUSINESSWIRE
21 Apr 2023
Share Share